Drug Detail

Information about Regorafenib + Envafolimab

Generic Name	Regorafenib + Envafolimab
IND
Brand Name (US)
Manufacturer
Drug Type
Delivery	Oral and Subcutaneous
Approval Status
Indications
Overall Strategy
Strategy
Drug Category	PD-L1 Antibody + KIT/PDGFRA inhibitor

Links
Trials of this drug
	A Study of Regorafenib Combined with Envafolimab for Metastatic Gastrointestinal Stromal Tumors with Kit Gene Exon 17 Mutation That Failed Standard Treatment

Trial results